C

CareDx
D

CDNA

15.165
USD
0.20
(1.30%)
مغلق
حجم التداول
28,795
الربح لكل سهم
-1
العائد الربحي
-
P/E
14
حجم السوق
843,124,517
أصول ذات صلة
ABT
ABT
-0.230
(-0.17%)
132.590 USD
BDX
BDX
-1.860
(-1.10%)
166.920 USD
DGX
DGX
-0.480
(-0.27%)
177.520 USD
HOLX
HOLX
-1.460
(-2.69%)
52.720 USD
IDXX
IDXX
3.21
(0.68%)
475.05 USD
ILMN
ILMN
0.315
(0.40%)
78.220 USD
PODD
PODD
1.93
(0.75%)
258.93 USD
TMO
TMO
-1.06
(-0.25%)
422.45 USD
المزيد
الأخبار المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.